Poland - Pharmaceutical products

Description

The subject matter of the contract is the supply of pharmaceutical products. The contract has been divided into parts and includes 46 packages.
BicalutamidumDetailed description of the order is in appendix no 2 to SWZ. OndansetronumA detailed description of the order is in appendix no. 2 to the SWZ. MesnumFor a detailed description of the order, see appendix no. 2 to the SWZ. Pos. 1 Capecitabinum film-coated tablets 150 mgPos. 2 Capecitabinum film-coated tablets 500 mgAttachment 2 to the SWZ provides a detailed description of the order. Pos. 1 Morphini sulfas solution for injection 10 mg/mlPos. 2 Morphini sulfas solution for injection 20 mg/mlPos. 3 OxazepamPos. 4 DiazepamumPos. 5 LormetazepamumPos. 6 ClonazepamumPos. 7 MidazolamumFor a detailed description of the order, see appendix 2 to the SWZ. Pos. 1 Midazolamum solution for injection 5 mg/mlPos. 2 Midazolamum solution for injection 15 mg/3 mlFor a detailed description of the order, see appendix 2 to the Terms of Reference. Pos. 1 Lidocaini hydrochloridum monohydricumPos. 2 Atropini sulfasPos. 3 Atropini sulfasPos. 4 ClemastinumPos. 5 Clemastini fumarasPos. 6 AdrenalinumPos. 7 DigoxinumPos. 8 TropicamidumFor a detailed description of the order, see attachment No. 2 to the SWZ. Pos. 1 BaclofenumPos. 2 Metoclopramidi hydrochloridumPos. 3 Metronidazolum solution for injection and infusionPos. 4 Metronidazolum tabletsPos. 5 Natrii hydrogenocarbonasPos. 6 Sulfacetamidum natricumFor a detailed description of the order, see appendix no. 2 to the SWZ. Pos. 1 AzithromycinumPos. 2 Formoteroli fumarasPos. 3 PantoprazolumPos. 4 Atorvastatinum film-coated tablets 10 mgPos. 5 Atorvastatinum film-coated tablets 20 mgPos. 6 Atorvastatinum film-coated tablets 40 mgPos. 7 AcetylcysteinumPos. 8 AciclovirumFor a detailed description of the order, see appendix 2 to the SWZ. Pos. 1 Dalteparinum natricum solution for injection 10 000 IU a.Xa/0.4 mlPos. 2 Dalteparinum natricum solution for injection 12 500 IU a.Xa/0.5 mlPos. 3 Dalteparinum natricum solution for injection 15 000 IU a.Xa/0.6 mlAttachment 4 Dalteparinum natricum solution for injection 18 000 IU. a.Xa/0.72 mlAttachment 5 Dalteparinum natricum solution for injection 5 000 IU. a.Xa/0.2 mlFor a detailed description of the order please refer to Appendix 2 to the SWZ. Item 1 Ramiprilum tablets 10 mgOther 2 Ramiprilum tablets 2.5 mgOther 3 Ramiprilum tablets 5 mgFor a detailed description of the order, see appendix 2 to the Terms of Reference. Pos. 1 Cefepimum powder for solution for injection and infusion 1 GP Pos. 2 Cefepimum powder for solution for injection and infusion 2 GS Detailed description of the order is provided in attachment No. 2 to the SWZ. Pos. 1 Carvedilolum film-coated tablets 6.25 mgCos. 2 Carvedilolum film-coated tablets 12.5 mgCos. 3 Carvedilolum film-coated tablets 25 mgFor a detailed description of the order, see Appendix 2 to the SWZ. Item 1 Dinatrii pamidronas powder and solvent for solution for infusion 60 mgAttachment 2 Dinatrii pamidronas powder and solvent for solution for infusion 90 mgAttachment 2 to the SWZ provides a detailed description of the order. Pos. 1 Ceftazidimum powder for solution for injection 500 mgPos. 2 Ceftazidimum powder for solution for injection 1 gPos. 3 Ceftazidimum powder for solution for injection 2 gFor detailed description of the order see appendix 2 to the SWZ. Pos. 1 Ceftriaxonum powder for solution for injection and infusion 1 g Pos. 2 Ceftriaxonum powder for solution for injection and infusion 2 g Detailed description of the order is provided in attachment No. 2 to the SWZ. DobutaminumA detailed description of the order is provided in appendix no. 2 to the SWZ. AprepitantumFor a detailed description of the order see appendix no. 2 to the SWZ. VoriconazolumFor a detailed description of the order, see appendix no. 2 to the SWZ. Pos. 1 Cefuroximum powder for solution or suspension for injection 750 mgPos. 2 Cefuroximum powder for solution for injection 1.5 gFor detailed description of the order see appendix 2 to the SWZ. Acidum ibandronicumA detailed description of the order is provided in appendix no. 2 to the SWZ. Amphotericinum BSFor a detailed description of the order see appendix no. 2 to the SWZ. IodixanolumA detailed description of the order is attached as Appendix 2 to the SWZ. Ornithini aspartasA detailed description of the order is attached as Annex 2 to the SWZ. Item 1 PolyvinoxPos. 2 GliclazidumPos. 3 ClarithromycinumPos. 4 Insulinum humanum type M3Pos. 5 GlucosumPos. 6 Inosinum pranobexumPos. 7 Hydrocortisoni acetasPos. 8 Hydroxyzini hydrochloridumPos. 9 Clonidini hydrochloridumPos. 10 Verapamili hydrochloridumPos. 11 PancreatinumPos. 12 PancreatinumPos. 13 Levothyroxinum natricumPos. 14 Lidocaini hydrochloridumPos. 15 Lidocaini hydrochloridumPos. 16 PiracetamumPos. 17 PhenobarbitalumPos. 18 Oleum Jecoris aselliPos. 19 ThiamazolumPos. 20 Isosorbidi mononitrasPos. 21 MontelukastumPos. 22 Ambroxoli hydrochloridumPos. 23 Tolperisoni hydrochloridumPos. 24 Nifuroxazidum coated tabletsPos. 25 Nifuroxazidum oral suspensionPos. 26 NorfloxacinumPos. 27 Hypoallergenic milk replacer containing casein hydrolysate and Lactobacillus GG for dietary management, containing all nutrients to meet the nutritional needs of the infantPos. 28 Hypoallergenic milk replacer containing casein hydrolysate and Lactobacillus GG for dietary management, suitable as part of a varied dietPos 29 LynestrenolumPos 30 Promethazini hydrochloridumPos 31 PentoxifyllinumPos 32 Diphenoxylati hydrochloridum + Atropini sulfasPos 33 Rocuronii bromidumPos 34 Propafenoni hydrochloridumPos 35 SulfasalazinumPos. 36 Hyoscini butylbromidumPos. 37 Hyoscini butylbromidumPos. 38 DiosmectitumPos. 39 Cefoperazonum + SulbactamumPos. 40 TheophyllinumPos. 41 Retinoli palmitasPos. 42 Pyridoxini hydrochloridumPos. 43 Colecalciferolum + RetinolumPos. 44 SulodexidumFor detailed description of the order please see appendix no. 2 to the SWZ. Item 1 Lauromacrogolum 4002 Fenoteroli hydrobromidum + Ipratropii bromidum3 Sugammadexum4 Azathioprinum5 Dexpanthenolum6 Diclofenacum natricum7 Mometasoni furoas ointment8 Mometasoni furoas cream9 Saccharomyces boulardii10 Acidum fusidicum11 Bencyclani fumaras12 Hydrochlorothiazidum13 Quetiapinum14 Oxytocinum15 Benzylpenicillinum procainum16 Benzylpenicillinum kalicum17 Betahistini dihydrochloridum18 Promazini hydrochloridum19 Simvastatinum20 Spironolactonum tablets 25 mg21 Spironolactonum film-coated tablets 100 mg22 Levetiracetamum film-coated tablets 250 mg23 Levetiracetamum film-coated tablets 1000 mg24 Rifaximinum25 Cefuroximum26 Talc, Solanum Tuberosum Starch, Zink Oxide, AllantoinFor a detailed description of the order please see appendix no. 2 to the SWZ. 1 Acidum acetylsalicylicum2 Proxymetacaini hydrochloridum3 Cetirizini dihydrochloridum4 Amitriptylini hydrochloridum5 Ampicillinum6 Dimenhydrinatum7 GOS/FOS oligosaccharide composition, docosahexaenoic acid (DHA) long-chain polyunsaturated fatty acid (LCPUFA), of the omega 3 group, in an amount of 0,32 % of the total fatty acids nucleotides essential vitamins and minerals the product does not contain genetically modified ingredients (GMO)8 Fenoteroli hydrobromidum + Ipratropii bromidum9 Thrombinum bovinum10 Ticagrelorum11 Hyoscini butylbromidum12 Captoprilum13 Mycophenolas mofetil14 Natrii picosulfas + Magnesii oxidum leve + Acidum citricum15 Suxamethonii chloridum16 Glyceroli suppositoria17 Ambroxoli hydrochloridum18 Macrogolum 335019 Macrogolum 3350 from 6 months of age20 Betamethasoni dipropionas + Betamethasoni natrii phosphas21 Isosorbidi mononitras22 Enalaprili maleas tablets 5 mg23 Enalaprili maleas tablets 10 mg24 Chlorpromazini hydrochloridum25 Carbamazepinum26 Fluconazolum27 Flumazenilum28 Tioguaninum29 Cosmetic oil with pump30 Carbo activatus31 Cholini salicylas32 Paracetamolum33 Benzyli benzoas, mineral oil, parfum34 Ampicillinum + Sulbactamum35 Rivaroxabanum36 Olanzapinum hard capsules37 Olanzapinum film-coated tabletsFor a detailed description of the order please see attachment No. 2 to the SWZ. GlucosumFor a detailed description of the order see appendix no. 2 to the SWZ. Natrium chloratum 0.9% NaClFor a detailed description of the order please see attachment No. 2 to the SWZ. Item 1 Aqua pro injectione solvent for parenteral drug preparation, 100 ml capacity Item 2 Aqua pro injectione solvent for parenteral drug preparation, 500 ml capacity with two independent portsFor a detailed description of the order, see appendix 2 to the Terms of Reference. 20% fat emulsion for parenteral nutrition containing only long-chain fatty acidsFor a detailed description of the order, see appendix no. 2 to the Terms of Reference. Item 1 Triple-chamber bag for parenteral nutrition for adults with the following content: glucose 63 g, nitrogen 4 g, lipids 19 g, to be administered through the central vein with the volume of 493 ml Item 2 Triple-chamber bag for parenteral nutrition for adults with the following content: glucose 125 g, nitrogen 8 g, lipids 38 g, to be administered through the central vein with the volume of 986 mlFor a detailed description of the order, see appendix 2 to the Terms of Reference. Triple-chamber bag for parenteral nutrition for adults with the following content: glucose 86, nitrogen 10.6g, lipids 29.2g, to be administered through a central vein with the volume of 1 012 mlFor a detailed description of the order, see appendix 2 to the Terms of Reference. Triple-chamber bag for parenteral nutrition for adults with the following content: glucose 129, nitrogen 15.9g, lipids 43.8g, for administration through a central vein with the volume of 1 518 mlFor a detailed description of the order, see appendix no. 2 to the Terms of Reference. Complete high energy diet (1.5 kcal/ml), rich in protein, fats and EPA and DHA from fish oil. It contains fiber and MCTS. Detailed description of the order is attached as Annex 2 to the SWZ. Incomplete diet high energy (1.5 kcal/ml), low protein (4 g/100 ml), carbohydrate 33.5 g/100 ml, fat free, gluten free, cherry flavored 200 ml Detailed description of the order is attached as Annex 2 to the SWZ. Item 1 Mannitolum solution for infusion 150 mg/ml bag. 100 mlPosition 2 Mannitolum 150 mg/ml solution for infusion in bag. 250 mlFor a detailed description of the order, see appendix no. 2 to the SWZ. Clear liquid preparation based on maltodextrins (0.5 kca/ml) for use in surgical patients for preoperative rehydration to reduce preoperative stress and to prevent postoperative insulin resistance, containing carbohydrates (12.6 g/100 ml) and electrolytes, non-stick with osmolarity 240 mOsmol/l with lemon flavorFor detailed description of the order is contained in Annex 2 to the SWZ. item 1 Vincristini sulfas solution for injection 1 mg/ml 1 vial 1 ml item 2 Vincristini sulfas solution for injection 1 mg/ml 1 vial 5 ml Pos. 1 Vinorelbinum concentrate for solution for infusion 10 mg/ml* 10 vials a 1 ml pos. 2 Vinorelbinum concentrate for solution for infusion 10 mg/ml* 10 vials a 5 ml Pos. 1 Pemetrexedum, powder for concentrate for solution for infusion 100 mgPos. 2 Pemetrexedum, powder for concentrate for solution for infusion 500 mgPos. 3 Pemetrexedum, powder for concentrate for solution for infusion 1,000 mg**A detailed description of the order is provided in attachment no. 2 to the SWZ. MelphalanumFor a detailed description of the order, see appendix no. 2 to the SWZ. Fludarabini phosphasFor a detailed description of the order, see appendix no. 2 to the SWZ. Vinblastini sulfasFor a detailed description of the order, see appendix no. 2 to the SWZ.

Opportunity closing date

03 August 2021

Value of contract

to be confirmed